Cargando…
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models
BACKGROUND: Mutations in the estrogen receptor alpha (ERα) 1 gene (ESR1) are frequently detected in ER+ metastatic breast cancer, and there is increasing evidence that these mutations confer endocrine resistance in breast cancer patients with advanced disease. However, their functional role is not w...
Autores principales: | Bahreini, Amir, Li, Zheqi, Wang, Peilu, Levine, Kevin M., Tasdemir, Nilgun, Cao, Lan, Weir, Hazel M., Puhalla, Shannon L., Davidson, Nancy E., Stern, Andrew M., Chu, David, Park, Ben Ho, Lee, Adrian V., Oesterreich, Steffi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442865/ https://www.ncbi.nlm.nih.gov/pubmed/28535794 http://dx.doi.org/10.1186/s13058-017-0851-4 |
Ejemplares similares
-
Detection of ESR1 mutations in circulating cell-free DNA from patients with metastatic breast cancer treated with palbociclib and letrozole
por: Gyanchandani, Rekha, et al.
Publicado: (2016) -
Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer
por: Li, Zheqi, et al.
Publicado: (2022) -
Non-coding single nucleotide variants affecting estrogen receptor binding and activity
por: Bahreini, Amir, et al.
Publicado: (2016) -
Targeted mutation detection in breast cancer using MammaSeq™
por: Smith, Nicholas G., et al.
Publicado: (2019) -
Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma
por: Tasdemir, Nilgun, et al.
Publicado: (2020)